$AMRN
AMARIN CORP PLC\UK

2024 Q3 Form 10-Q Financial Statement

#000095017024118990 Filed on October 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $42.30M
YoY Change -35.97%
Cost Of Revenue $26.02M
YoY Change 10.26%
Gross Profit $16.28M
YoY Change -45.42%
Gross Profit Margin 38.48%
Selling, General & Admin $36.90M
YoY Change -18.82%
% of Gross Profit 226.74%
Research & Development $4.540M
YoY Change -11.07%
% of Gross Profit 27.89%
Depreciation & Amortization $753.0K
YoY Change 1.76%
% of Gross Profit 4.63%
Operating Expenses $41.44M
YoY Change -19.17%
Operating Profit -$25.17M
YoY Change 17.33%
Interest Expense $3.374M
YoY Change 4.91%
% of Operating Profit
Other Income/Expense, Net $265.0K
YoY Change -146.09%
Pretax Income -$21.53M
YoY Change 14.46%
Income Tax $3.605M
% Of Pretax Income
Net Earnings -$25.13M
YoY Change 30.15%
Net Earnings / Revenue -59.42%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$0.06
COMMON SHARES
Basic Shares Outstanding 411.2M
Diluted Shares Outstanding 411.2M

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $305.7M
YoY Change -4.67%
Cash & Equivalents $156.9M
Short-Term Investments $148.8M
Other Short-Term Assets $7.842M
YoY Change -60.79%
Inventory $224.0M
Prepaid Expenses
Receivables $112.6M
Other Receivables $0.00
Total Short-Term Assets $650.2M
YoY Change -9.38%
LONG-TERM ASSETS
Property, Plant & Equipment $24.00K
YoY Change -83.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.250M
YoY Change -10.39%
Total Long-Term Assets $100.4M
YoY Change -17.37%
TOTAL ASSETS
Total Short-Term Assets $650.2M
Total Long-Term Assets $100.4M
Total Assets $750.6M
YoY Change -10.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $40.51M
YoY Change -24.09%
Accrued Expenses $161.0M
YoY Change -23.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $201.6M
YoY Change -24.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $9.471M
YoY Change 30.22%
Total Long-Term Liabilities $9.471M
YoY Change 30.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $201.6M
Total Long-Term Liabilities $9.471M
Total Liabilities $219.2M
YoY Change -23.31%
SHAREHOLDERS EQUITY
Retained Earnings -$1.620B
YoY Change 2.49%
Common Stock $305.2M
YoY Change 0.95%
Preferred Stock
YoY Change
Treasury Stock (at cost) $65.34M
YoY Change 2.51%
Treasury Stock Shares
Shareholders Equity $531.4M
YoY Change
Total Liabilities & Shareholders Equity $750.6M
YoY Change -10.54%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$25.13M
YoY Change 30.15%
Depreciation, Depletion And Amortization $753.0K
YoY Change 1.76%
Cash From Operating Activities -$2.360M
YoY Change -132.2%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$56.55M
YoY Change -283.79%
Cash From Investing Activities -$56.55M
YoY Change -283.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -68.00K
YoY Change -74.81%
NET CHANGE
Cash From Operating Activities -2.360M
Cash From Investing Activities -56.55M
Cash From Financing Activities -68.00K
Net Change In Cash -58.98M
YoY Change -255.91%
FREE CASH FLOW
Cash From Operating Activities -$2.360M
Capital Expenditures $0.00
Free Cash Flow -$2.360M
YoY Change -132.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000897448
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
AMARIN CORP PLC\UK
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2023 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.amarincorp.com/20240930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-21392
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
X0
dei Entity Address Address Line1
EntityAddressAddressLine1
One Central Plaza
dei Entity Address Address Line2
EntityAddressAddressLine2
5th Floor
dei Entity Address Address Line3
EntityAddressAddressLine3
36 Dame Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
2
dei Entity Address Country
EntityAddressCountry
IE
dei City Area Code
CityAreaCode
353 (0) 1
dei Local Phone Number
LocalPhoneNumber
6699 020
dei Security12b Title
Security12bTitle
American Depositary Shares (ADS(s)), each ADSrepresenting the right to receive one (1) Ordinary Share ofAmarin Corporation plc
dei Trading Symbol
TradingSymbol
AMRN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156944000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199252000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
526000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
525000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
148788000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
121407000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
112642000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
133563000
CY2024Q3 us-gaap Inventory Net
InventoryNet
224000000
CY2023Q4 us-gaap Inventory Net
InventoryNet
258616000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7316000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11618000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
650216000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
724981000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
114000
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
74023000
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
77615000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7984000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8310000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1250000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1360000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17118000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19304000
CY2024Q3 us-gaap Assets
Assets
750615000
CY2023Q4 us-gaap Assets
Assets
831684000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
40507000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
52762000
CY2024Q3 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
161047000
CY2023Q4 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
204174000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2341000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
201554000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
259277000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2509000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8215000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8737000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9471000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9064000
CY2024Q3 us-gaap Liabilities
Liabilities
219240000
CY2023Q4 us-gaap Liabilities
Liabilities
279587000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.5
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.5
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
421994431
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
411261678
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
418141295
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
408824093
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
305202000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
302756000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1911445000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1899456000
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
10732753
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9317202
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
65344000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
63752000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1619928000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1586363000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
531375000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
552097000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
750615000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
831684000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42298000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66056000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166308000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232198000
CY2024Q3 us-gaap Cost Direct Material
CostDirectMaterial
26022000
CY2023Q3 us-gaap Cost Direct Material
CostDirectMaterial
23560000
us-gaap Cost Direct Material
CostDirectMaterial
75359000
us-gaap Cost Direct Material
CostDirectMaterial
72553000
CY2024Q3 amrn Cost Of Goods And Services Sold Restructuring Inventory
CostOfGoodsAndServicesSoldRestructuringInventory
0
CY2023Q3 amrn Cost Of Goods And Services Sold Restructuring Inventory
CostOfGoodsAndServicesSoldRestructuringInventory
12674000
amrn Cost Of Goods And Services Sold Restructuring Inventory
CostOfGoodsAndServicesSoldRestructuringInventory
0
amrn Cost Of Goods And Services Sold Restructuring Inventory
CostOfGoodsAndServicesSoldRestructuringInventory
39228000
CY2024Q3 us-gaap Gross Profit
GrossProfit
16276000
CY2023Q3 us-gaap Gross Profit
GrossProfit
29822000
us-gaap Gross Profit
GrossProfit
90949000
us-gaap Gross Profit
GrossProfit
120417000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36904000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45457000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
115340000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
155997000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4540000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5105000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14884000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16428000
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
711000
us-gaap Restructuring Charges
RestructuringCharges
10743000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
41444000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
51273000
us-gaap Operating Expenses
OperatingExpenses
130224000
us-gaap Operating Expenses
OperatingExpenses
183168000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25168000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21451000
us-gaap Operating Income Loss
OperatingIncomeLoss
-39275000
us-gaap Operating Income Loss
OperatingIncomeLoss
-62751000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3374000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3216000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
10028000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
8438000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
265000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-575000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1954000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3092000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21529000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18810000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27293000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51221000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3605000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
501000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6272000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2110000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-25134000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-19311000
us-gaap Net Income Loss
NetIncomeLoss
-33565000
us-gaap Net Income Loss
NetIncomeLoss
-53331000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
411150000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
408417000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
410786000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
407489000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
411150000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
408417000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
410786000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
407489000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
552097000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1436000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5218000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-9953000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
545936000
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
122000
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-88000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4387000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1522000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
551879000
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-68000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4698000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-25134000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
531375000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
595333000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1871000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1507000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5556000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-16460000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
584793000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
240000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-187000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1835000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-17560000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
569128000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-279000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3608000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-19311000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
553148000
us-gaap Profit Loss
ProfitLoss
-33565000
us-gaap Profit Loss
ProfitLoss
-53331000
amrn Depreciation And Amortization Excluding Amortization Of Intangible Assets
DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets
90000
amrn Depreciation And Amortization Excluding Amortization Of Intangible Assets
DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets
127000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
4163000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2583000
us-gaap Share Based Compensation
ShareBasedCompensation
14303000
us-gaap Share Based Compensation
ShareBasedCompensation
10999000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2186000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2104000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20921000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8590000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-38208000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-46099000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4471000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-28000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-110000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
313000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
250000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-204000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4850000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10372000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-55382000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
7386000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
211000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1413000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17710000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7525000
amrn Disposal Purchase Of Furniture Fixtures And Equipment
DisposalPurchaseOfFurnitureFixturesAndEquipment
0
amrn Disposal Purchase Of Furniture Fixtures And Equipment
DisposalPurchaseOfFurnitureFixturesAndEquipment
-24000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
185800000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
160997000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
208937000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
115496000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23137000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
45477000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
122000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
240000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1880000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1592000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1973000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1460000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
147000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42307000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
53149000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
199777000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
218189000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
157470000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
271338000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2045000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1103000
amrn Initial Recognition Of Operating Lease Right Of Use Asset
InitialRecognitionOfOperatingLeaseRightOfUseAsset
1068000
amrn Initial Recognition Of Operating Lease Right Of Use Asset
InitialRecognitionOfOperatingLeaseRightOfUseAsset
430000
amrn Initial Recognition Of Furniture Fixtures And Equipment Lease
InitialRecognitionOfFurnitureFixturesAndEquipmentLease
0
amrn Initial Recognition Of Furniture Fixtures And Equipment Lease
InitialRecognitionOfFurnitureFixturesAndEquipmentLease
624000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q3 us-gaap Assets
Assets
750600000
CY2024Q3 amrn Cash And Short Term Investments
CashAndShortTermInvestments
305700000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
650200000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156900000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
148800000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
112600000
CY2024Q3 us-gaap Inventory Net
InventoryNet
224000000
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
74000000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0
amrn Accounts Receivable Credit Period
AccountsReceivableCreditPeriod
P45D
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
130254000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
160686000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
112642000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
133563000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25134000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-25134000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19311000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-19311000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33565000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-33565000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-53331000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-53331000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
411150000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
411150000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
408417000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
408417000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
410786000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
410786000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
407489000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
407489000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:2.267%;font-size:10pt;margin-top:13.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. The Company maintains substantially all of its cash and cash equivalents and short-term and long-term investments in financial institutions believed to be of high credit quality.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A significant portion of the Company’s sales are to wholesalers in the pharmaceutical industry. The Company monitors the creditworthiness of customers to whom it grants credit terms and has not experienced any credit losses. The Company does not require collateral or any other security to support credit sales. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">Three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customers individually accounted for 10% or more of the Company’s gross product sales. Customers A, B, and C accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">29</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">34</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">28</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively, of gross product sales for the nine months ended September 30, 2024, and represented </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">41</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">17</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively, of the gross accounts receivable balance as of September 30, 2024. Customers A, B, and C accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">36</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">29</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively, of gross product sales for the nine months ended September 30, 2023 and represented </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">37</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">37</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">22</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively, of the gross accounts receivable balance as of September 30, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company has not experienced any significant write-offs of its accounts receivable. All customer accounts are actively managed and no losses in excess of amounts reserved are currently expected.</span></p>
us-gaap Debt Instrument Term
DebtInstrumentTerm
P24M
CY2024Q3 amrn Held To Maturity Securities Continuous Unrealized Gain Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedGainLossPositionFairValue
300000
CY2023Q3 amrn Held To Maturity Securities Continuous Unrealized Gain Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedGainLossPositionFairValue
-100000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 amrn Cost Of Goods And Services Sold Restructuring Inventory
CostOfGoodsAndServicesSoldRestructuringInventory
12700000
amrn Cost Of Goods And Services Sold Restructuring Inventory
CostOfGoodsAndServicesSoldRestructuringInventory
39200000
amrn Restructuring Expenses
RestructuringExpenses
10154000
CY2023Q3 amrn Vendor Contract Charges
VendorContractCharges
711000
amrn Vendor Contract Charges
VendorContractCharges
589000
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
711000
us-gaap Restructuring Charges
RestructuringCharges
10743000
CY2023Q3 amrn Cost Of Goods And Services Sold Restructuring Inventory
CostOfGoodsAndServicesSoldRestructuringInventory
12674000
amrn Cost Of Goods And Services Sold Restructuring Inventory
CostOfGoodsAndServicesSoldRestructuringInventory
39228000
CY2023Q3 amrn Restructuring Charges Stock Forfeitures
RestructuringChargesStockForfeitures
1034000
amrn Restructuring Charges Stock Forfeitures
RestructuringChargesStockForfeitures
1034000
CY2023Q3 amrn Restructuring Charges Includes Cost Of Goods Sold Restructuring Inventory
RestructuringChargesIncludesCostOfGoodsSoldRestructuringInventory
14419000
amrn Restructuring Charges Includes Cost Of Goods Sold Restructuring Inventory
RestructuringChargesIncludesCostOfGoodsSoldRestructuringInventory
51005000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
13589000
amrn Restructuring Costs Incurred
RestructuringCostsIncurred
0
us-gaap Payments For Restructuring
PaymentsForRestructuring
3687000
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
9902000
CY2024Q3 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P6Y3M18D
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33188000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33188000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16070000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13884000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17118000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19304000
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
145352000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
155128000
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
32088000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
5373000
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
120583000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
175730000
CY2024Q3 amrn Inventory Current And Non Current
InventoryCurrentAndNonCurrent
298023000
CY2023Q4 amrn Inventory Current And Non Current
InventoryCurrentAndNonCurrent
336231000
CY2024Q3 amrn Inventory Deemed Not Saleable
InventoryDeemedNotSaleable
0
amrn Inventory Deemed Not Saleable
InventoryDeemedNotSaleable
1500000
CY2023Q3 amrn Finished Goods Deemed Not Saleable
FinishedGoodsDeemedNotSaleable
0
amrn Finished Goods Deemed Not Saleable
FinishedGoodsDeemedNotSaleable
3400000
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
74000000
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
77600000
CY2024Q3 us-gaap Purchase Obligation
PurchaseObligation
53000000
CY2024Q2 amrn Maximum Triggering Obligations Amount
MaximumTriggeringObligationsAmount
15800000
CY2024Q3 amrn Accured Estimated Liability
AccuredEstimatedLiability
7800000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9500
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1239763
amrn Proceeds From Stock Options Exercised Gross
ProceedsFromStockOptionsExercisedGross
10260
amrn Proceeds From Stock Options Exercised Gross
ProceedsFromStockOptionsExercisedGross
1878000
amrn Accounts Receivable Credit Period
AccountsReceivableCreditPeriod
P45D
CY2023Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
171501000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
661470000
amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
2111000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
542351000
amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
160109000
CY2024Q3 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
128400000
CY2022Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
191521000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
613701000
amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
15257000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
485808000
amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
119913000
CY2023Q3 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
184244000
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4850000
amrn Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
4850000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
15346000
amrn Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
5000000
amrn Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
15372000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4974000
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4900000
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
15000000
amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
1180000
amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
11479000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
3670000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1722000
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.115
amrn Operating Lease Change In Weighted Average Discount Rate Percent
OperatingLeaseChangeInWeightedAverageDiscountRatePercent
0.01
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
10200000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10600000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8000000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8300000
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2700000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1700000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
791000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2908000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2563000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1967000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1978000
CY2024Q3 amrn Lessee Operating Lease Liability Payments Due Year Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter
3273000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13480000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3327000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1938000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8215000
CY2024Q3 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
15000
CY2023Q3 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
17000
us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
47000
us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
44000
CY2024Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
249000
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
249000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
746000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
663000
us-gaap Sales Type Lease Impairment Loss
SalesTypeLeaseImpairmentLoss
61000
CY2024Q3 us-gaap Lease Income
LeaseIncome
264000
CY2023Q3 us-gaap Lease Income
LeaseIncome
266000
us-gaap Lease Income
LeaseIncome
793000
us-gaap Lease Income
LeaseIncome
646000
CY2024Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
29000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
252000
CY2024Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
119000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
1029000
CY2024Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
122000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
1051000
CY2024Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
125000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
1073000
CY2024Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
127000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
1096000
CY2024Q3 amrn Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years And Thereafter
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYearsAndThereafter
345000
CY2024Q3 amrn Lessor Operating Lease Payments To Be Received Five Years And Thereafter
LessorOperatingLeasePaymentsToBeReceivedFiveYearsAndThereafter
2974000
CY2024Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
867000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
7475000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-118990-index-headers.html Edgar Link pending
0000950170-24-118990-index.html Edgar Link pending
0000950170-24-118990.txt Edgar Link pending
0000950170-24-118990-xbrl.zip Edgar Link pending
amrn-20240930.htm Edgar Link pending
amrn-20240930.xsd Edgar Link pending
amrn-ex10_1.htm Edgar Link pending
amrn-ex31_1.htm Edgar Link pending
amrn-ex31_2.htm Edgar Link pending
amrn-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img153238507_0.jpg Edgar Link pending
img195770556_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
amrn-20240930_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable